Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

1. SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET

   NOT YET RECRUITING → RECRUITING

   Recorded 2026-10-16

   View record

2. RETRACTED: Image recognition of CT diagnosis for cholangiocarcinoma treatment based on FPGA processor and neural network

   Retraction flag: retracted

   Recorded 2026-10-16

   View record

3. Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

   RECRUITING → ACTIVE NOT RECRUITING

   Recorded 2026-10-14

   View record

4. Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma

   NOT YET RECRUITING → RECRUITING

   Recorded 2026-10-14

   View record

5. Agnostic Therapy in Rare Solid Tumors

   RECRUITING → ACTIVE NOT RECRUITING

   Recorded 2026-10-14

   View record